Access the full text.
Sign up today, get DeepDyve free for 14 days.
A. Blanco, M. Cardozo, M. Candela, M. Santarelli, R. Bianco, M. Lazzari (1997)
Anti-factor VIII Inhibitors and Lupus Anticoagulants in Haemophilia A PatientsThrombosis and Haemostasis, 77
A. Cohen, C. Kessler (1996)
9 Acquired inhibitorsBaillière's clinical haematology, 9
C. Négrier, J. Goudemand, Y. Sultan, Marie-Anne Bertrand, Chantal Rothschild, P. Lauroua (1997)
Multicenter Retrospective Study on the Utilization of FEIBA in France in Patients with Factor VIII and Factor IX InhibitorsThrombosis and Haemostasis, 77
M. Flaherty, M. Wener (1989)
Antibodies to thrombin in postsurgical patients [letter; comment]Blood, 73
D. Triplett (1995)
Antiphospholipid-protein antibodies: laboratory detection and clinical relevance.Thrombosis research, 78 1
A. Delmer, M. Horellou, G. Andreu, T. Lecompte, F. Rossi, M. Kazatchkine, M. Samama, R. Zittoun (1989)
Life-threatening intracranial bleeding associated with the presence of an antifactor VII autoantibody.Blood, 74 1
L. Rao, A. Zivelin, Ignacio Iturbe, S. Rapaport (1994)
Antibody-Induced Acute Factor X Deficiency: Clinical Manifestations and Properties of the AntibodyThrombosis and Haemostasis, 72
D. Spronsen, J. Oosting, J. Hoffmann, W. Breed (1998)
Factor V inhibitor associated with cold agglutinin diseaseAnnals of Hematology, 76
Arthur Thompson, Michael Murphy, Miao-Liang Liu, E. Saenko, John Healey, Pete Lollar, D. Scandella (1997)
Loss of tolerance to exogenous and endogenous factor VIII in a mild hemophilia A patient with an Arg593 to Cys mutation.Blood, 90 5
P. Capel, M. Toppet, E. Remoortel, P. Fondu (1986)
FACTOR VIII INHIBITOR IN MILD HAEMOPHILIABritish Journal of Haematology, 62
I. Nilsson, E. Berntorp, C. Freiburghaus (1993)
Treatment of Patients with Factor VIII and IX InhibitorsThrombosis and Haemostasis, 70
A. Giles, B. Verbruggen, G. Rivard, J. Teitel, I. Walker (1998)
A Detailed Comparison of the Performance of the Standard versus the Nijmegen Modification of the Bethesda Assay in Detecting Factor VIII:C Inhibitors in the Haemophilia A Population of CanadaThrombosis and Haemostasis, 79
R. Furlong, I. Peake, A. Bloom (1981)
Factor VIII Clotting Antigen (VIIICAg) in Haemophilia Measured by Two Immunoradiometric Assays (IRMA) using Different Antibodies, and the Measurement of Inhibitors to Procoagulant Factor VIII (VIIIC) by IRMABritish Journal of Haematology, 48
R. Biggs, D. Austen, K. Denson, R. Borrett, C. Rizza (1972)
The Mode of Action of Antibodies which Destroy Factor VIIIBritish Journal of Haematology, 23
D. Stern, H. Nossel, J. Owen (1982)
Acquired antibody to factor XI in a patient with congenital factor XI deficiency.The Journal of clinical investigation, 69 6
H. Brackmann, J. Oldenburg, R. Schwaab (1996)
Immune Tolerance for the Treatment of Factor VIII Inhibitors ‐ Twenty Years' ‘Bonn Protocol’Vox Sanguinis, 70
A. Matsunaga, F. Shafer (1996)
An Acquired Inhibitor to Factor X In a Pediatric Patient with Extensive BurnsJournal of Pediatric Hematology/Oncology, 18
JM Lavergne, D. Meyer, H. Reisner (1976)
Characterization of human anti-factor VIII antibodies purified by immune complex formation.Blood, 48 6
Sherman La, Goldstein Ma, Sise Hs (1969)
Circulating anticoagulant (antifactor 8 treated with immunosuppressive drugs.Thrombosis et diathesis haemorrhagica, 21
C. Lee, C. Kessler, D. Varon, U. Martinowitz, M. Heim, C. Hay (1998)
Factor VIII inhibitors in mild and moderate‐severity haemophilia AHaemophilia, 4
B. Macik, C. Lindley, J. Lusher, W. Sawyer, A. Bloom, J. Harrison, K. Baird-Cox, K. Birch, S. Glazer, H. Roberts (1993)
Safety and initial clinical efficacy of three dose levels of recombinant activated factor VII (rFVIIa): results of a Phase I studyBlood Coagulation & Fibrinolysis, 4
D. Weisdorf, D. Arthur, J. Rank, B. Blazar, K. Gajl-Peczalska, D. Snover (1989)
GASTRIC RECURRENCE OF ACUTE LYMPHOBLASTIC LEUKAEMIA MIMICKING GRAFT‐VERSUS‐HOST DISEASEBritish Journal of Haematology, 71
Joan Fox (1996)
Platelet activation: new aspects.Haemostasis, 26 Suppl 4
Satoko Nakamura, A. Kato, Y. Sakata, N. Aoki (1988)
Bleeding tendency caused by IgG inhibitor to factor XIII, treated successfully by cyclophosphamideBritish Journal of Haematology, 68
M. Scully, V. Ellis, V. Kakkar, G. Savidge, Y. Williams, H. Sterndale (1982)
An acquired coagulation inhibitor to factor IIBritish Journal of Haematology, 50
R. Schwaab, H. Brackmann, C. Meyer, J. Seehafer, M. Kirchgesser, A. Haack, K. Olek, E. Tuddenham, J. Oldenburg (1995)
Haemophilia A: Mutation Type Determines Risk of Inhibitor FormationThrombosis and Haemostasis, 74
J. Lusher, S. Shapiro, J. Palascak, A. Rao, P. Levine, P. Blatt (1980)
Efficacy of prothrombin-complex concentrates in hemophiliacs with antibodies to factor VIII: a multicenter therapeutic trial.The New England journal of medicine, 303 8
C. Lee, C. Kessler, D. Varon, U. Martinowitz, M. Heim, S. Schulman (1998)
Safety, efficacy and lessons from continuous infusion with rFVIIaHaemophilia, 4
R. Lottenberg, T. Kentro, C. Kitchens (1987)
Acquired Hemophilia: A Natural History Study of 16 Patients With Factor VIII Inhibitors Receiving Little or No TherapyJAMA Internal Medicine, 147
H. Aberg, I. Nilsson (2009)
Recurrent thrombosis in a young woman with a circulating anticoagulant directed against factors XI and XII.Acta medica Scandinavica, 192 5
G. Bray, E. Gomperts, S. Courter, R. Gruppo, EM Gordon, M. Manco‐Johnson, A. Shapiro, E. Scheibel, G. White, M. Lee (1994)
A multicenter study of recombinant factor VIII (recombinate): safety, efficacy, and inhibitor risk in previously untreated patients with hemophilia A. The Recombinate Study Group.Blood, 83 9
M. Barthels, N. Heimburger (1985)
Acquired thrombin inhibitor in a patient with liver cirrhosis.Haemostasis, 15 6
J. Brandt, D. Triplett, B. Alving, I. Scharrer (1995)
Criteria for the Diagnosis of Lupus Anticoagulants: An UpdateThrombosis and Haemostasis, 74
E. Santagostino, A. Gringeri, L. Tagliavacca, P. Mannucci (1995)
Inhibitors to Factor VIII in a Family with Mild Hemophilia: Molecular Characterization and Response to Factor VIII and DesmopressinThrombosis and Haemostasis, 74
K. Lechner (1971)
Factor IX-InhibitorsThrombosis and Haemostasis, 25
K. Peerlinck, F. Rosendaal, Jozef Vermylen (1993)
Incidence of inhibitor development in a group of young hemophilia A patients treated exclusively with lyophilized cryoprecipitate.Blood, 81 12
M. Brunod, C. Chatot-Henry, H. Mehdaoui, C. Richer, C. Fonteau (1998)
Acquired Anti-factor VII (Proconvertin) Inhibitor: Hemorrhage and ThrombosisThrombosis and Haemostasis, 79
D. Austen, K. Lechner, C. Rizza, I. Rhymes (1982)
A Comparison of the Bethesda and New Oxford Methods of Factor VIII Antibody AssayThrombosis and Haemostasis, 47
S. Cronberg, I. Nilsson (2009)
Circulating anticoagulant against factors XI and XII together with massive spontaneous platelet aggregation.Scandinavian journal of haematology, 10 4
B. Verbruggen, I. Nováková, H. Wessels, J. Boezeman, M. berg, E. Mauser-Bunschoten (1995)
The Nijmegen Modification of the Bethesda Assay for Factor VIII:C Inhibitors: Improved Specificity and ReliabilityThrombosis and Haemostasis, 73
C. Rizza, J. Edgcumbe, W. Pitney, J. Child (1972)
The Treatment of Patients Having Spontaneously Occurring Antibodies to Antihaemophilic Factor (Factor VIII)Thrombosis and Haemostasis, 28
H. Fukue, Kenneth Anderson, P. Mcphedran, LP Clyne, Jan McDonagh (1992)
A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA.Blood, 79 1
Inga Nilsson, Erik Berntorp, Olle Zettervall, B. Dahlbäck (1990)
Noncoagulation inhibitory factor VIII antibodies after induction of tolerance to factor VIII in hemophilia A patients.Blood, 75 2
K. Miller, J. Neely, W. Krivit, J. Edson (1978)
Spontaneously acquired factor IX inhibitor in a nonhemophiliac childThe Journal of Pediatrics, 93
Kangathevy Morgan, S. Schiffman, D. Feinstein (1984)
Acquired Factor XI Inhibitors in Two Patients with Hereditary Factor XI DeficiencyThrombosis and Haemostasis, 51
R. Stricker, P. Lane, J. Leffert, G. Rodgers, M. Shuman, L. Corash (1988)
Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves.Blood, 72 4
S. Bajaj, S. Rapaport, S. Barclay, K. Herbst (1985)
Acquired hypoprothrombinemia due to non-neutralizing antibodies to prothrombin: mechanism and management.Blood, 65 6
S. Zucker, M. Zarrabi, G. Romano, Frederick Miler (1978)
IgM Inhibitors of the Contact Activation Phase of Coagulation in Chlorpromazine‐ Treated PatientsBritish Journal of Haematology, 40
Margaret Hilgartner, Louis Aledort, A. Andes, Janusz Gill (1990)
Efficacy and safety of vapor‐heated anti‐inhibitor coagulant complex in hemophilia patients. FEIBA Study GroupTransfusion, 30
W. Muntean, W. Zenz, G. Edlinger, A. Beitzke (1997)
Severe Bleeding due to Factor V Inhibitor after Repeated Operations Using Fibrin Sealant Containing Bovine ThrombinThrombosis and Haemostasis, 77
R. Prescott, H. Nakai, E. Saenko, I. Scharrer, I. Nilsson, J. Humphries, D. Hurst, G. Bray, D. Scandella (1997)
The inhibitor antibody response is more complex in hemophilia A patients than in most nonhemophiliacs with factor VIII autoantibodies. Recombinate and Kogenate Study Groups.Blood, 89 10
S. Schnall, T. Duffy, L. Clyne (1987)
Acquired factor XI inhibitors in congenitally deficient patientsAmerican Journal of Hematology, 26
F. Malagón, F. Elorza, E. Martín, A. Jiménez (1980)
Quantification of Antibodies against Factor VIII by an Immunonephelometric Method in a Continuous-Flow SystemAnnals of Clinical Biochemistry, 17
C. Hay, C. Négrier, C. Ludlam (1997)
The Treatment of Bleeding in Acquired Haemophilia with Recombinant Factor VIIa: A Multicentre StudyThrombosis and Haemostasis, 78
R. Largo, P. Sigg, A. Felten, P. Straub (1974)
Acquired Factor‐IX Inhibitor in a Nonhaemophilic Patient with Autoimmune Disease *British Journal of Haematology, 26
R. Großmann, H. Wankmüller, S. Schwender, J. Kirschner, B. Mansouri-Taleghani, F. Keller, K. Kochsiek (2008)
Diagnose und Therapie eines erworbenen Faktor-VIII-Inhibitors in Kombination mit Lupus-AntikoagulanzienDMW, 121
L. Brickner, K. Scannell, M. Sahud (1996)
Acquired factor V inhibitor in a patient with acquired human immunodeficiency syndromeAmerican Journal of Hematology, 52
J. Lusher, S. Arkin, C. Abildgaard, R. Schwartz (1993)
Recombinant factor VIII for the treatment of previously untreated patients with hemophilia A. Safety, efficacy, and development of inhibitors. Kogenate Previously Untreated Patient Study Group.The New England journal of medicine, 328 7
Collins Hw, Gonzalez Mf (1984)
Acquired Factor IX Inhibitor in a Patient with Adenocarcinoma of the ColonActa Haematologica, 71
C. Hay, J. Lozier, Christine Lee, M. Laffan, F. Tradati, E. Santagostino, N. Ciavarella, M. Schiavoni, Hiroshi Fukui, Akira Yoshioka, Jerome Teitel, P. Mannucci, C. Kasper (1996)
Safety Profile of Porcine Factor VIII and Its Use as Hospital and Home-Therapy for Patients with Haemophilia-A and Inhibitors: the Results of An International SurveyThrombosis and Haemostasis, 75
E. Campbell, S. Sanal, J. Mattson, L. Walker, S. Estry, L. Mueller, M. Schwarz, S. Hampton (1980)
Factor VII inhibitor.The American journal of medicine, 68 6
bersicht Diagnostik und Therapiesteuerung bei erworbenen Faktoreninhibitoren K/> ;jfi'J Thorepy Monitoring in Palionte v/rth Acquired Coagulation Factor Inhibitors h 'jrofjrri:jr < ?;. fj^hwWKtor', F. mil von b<ff.ii<in«MiivlMj<ii<rJilr hat wrj'cii der cili/ui*;fil<ig?n · «I'M l IM ;<' · ·.* hti« II Mini niMfnv.eild /u *>ciii. Neben «I« Abpj« / «·; ^mr anyrboienen oder crwor|«* ;'>*;< |f>l vor ;il|r*ni «ftff Aunvchlu Mil· '.p· /di'i' h'-r fnbibnoirn. «lie vnnwfirf /.u Thmwbwri ', VMM l^«l<*MiiiMK. WithiJK Mil <lic Aimw.'ihl iter v u mi IHljcvl» Afi'wiy ^? Vcrlulircii ilif 'Ififi N'«< liwch von AnlikOiprrM, die einen Gcli'iiiiHn«* /M lilfi» ; ki«*ic?n, I'Oi die /^? MclM iK'tifr nil! l· V I I I , rckonibiiKiiilci I' VII . I'fMiljionil/inl 'M;i|>lf^p;/ij;iJriilcn und · cm l/icii^» 'i|><*klruiri an MO^IiclikuitcM V''il!iHMUH I;m* Cicrinnun^l^bdrafofiniri ?*tclll die f r <';»|?> wiclili^cn MeihodcM. wicCilo |;|*·'>, I'iii/rlhikloi'hc^lirniiiUM^cn und Mwkdr der I'lliiiiiMlyMi·, /nr V^rlOp.(nij/ t I'iir cinc IniniuntolcrMii/ihri;i|nc linden VMI idlcn» l^khiren^ubcii und ; F(iKu>r6iiiriiiii)iiorcn; M/Jmoplrilic/ ir; HliinM|iltilic/Hlut; Burriiiiory: A^iulicd coiigidini«in laclor iriliihliom In pfiiiciMn »nc IMIC Inn t'UMrtf? «tfvdrti bleeding und high < , LiihiH'Mtoiy diu{/.no»iif> h; he rapid and i'MinpiHii'iifiivr bct'MUfic ol J(N inipmiiincc (Or (he chukr »/I on inlc(|ii:iic liciiiiiicul op(ioi). Coa^idoiion I'liL'tui dcli'jienokifi und luin-wpccinc 1 inliibkom, which
Laboratoriums Medizin / Journal of Laboratory Medicine – de Gruyter
Published: Jan 1, 1999
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.